Topic: Patents

Latest content

Inside the patent portfolio Ericsson gets as part of its $6 billion Vonage acquisition

While not great in number, the incoming IP is of good quality and will boost the Swedish company’s presence in key areas such as security, machine learning and wired networks

26 November 2021

Big Chinese prosecution firms continue to ride the wave of rising patent filings

Prosecution data shows the patent agencies in China that obtain the most patents for clients in key technical fields

26 November 2021

Balance and clarity are the top US policy priorities for patent leaders

On the sidelines of IPBC Global last week, IP executives from Xperi, Hewlett Packard Enterprise, IBM, Valo Health and Aon IP Solutions identified what they see as the most pressing issues

25 November 2021

Latest patent sale by Chinese lab shows hot demand for 5G assets

Research outfit Shanghai Langbo has found customers among both operating companies and licensing firms for its recent patent output

25 November 2021

“Every crisis brings about innovation" – how the vaccine race is transforming biopharma IP

From greater respect for researchers to a fresh focus on compulsory licences, IAM’s Global Leaders share their views on how the life sciences space has been changed by the quest for covid-19 vaccines

24 November 2021

How to deal with China's new crackdown on bad-faith patent filings and other examination changes

The Long Read: New guidelines in the works at the CNIPA will continue the fight against 'irregular' applications, make utility models harder to get and heighten the risk of litigation in the software space, write Aaron Wininger of Schwegman Lundberg & Woessner, PA and Austin Chang of Beijing East IP

24 November 2021

Hyundai Motor bolsters portfolio in patent assignment deal with AT&T

Korean automaker acquires dozens of assets in areas including drone technology and speech processing

24 November 2021

Corporate IP heads reveal invention harvesting tricks of the trade

Leaders from Johnson Controls, JUUL Labs, Valo Health and IBM discuss tried-and-true methods of capturing innovation, as well as lessons learned from the pandemic

23 November 2021

Novo Nordisk’s $3.3 billion Dicerna purchase shows booming RNA IP market

Danish company makes its biggest-ever acquisition in an area where demand for assets is growing rapidly

23 November 2021

US patent system due for a mid-course correction, says IBM's IP business head

Bill LaFontaine says the current challenging licensing environment stems not only from legal and policy factors, but also from a widespread cultural shift that has normalised infringement

22 November 2021

Unlock unlimited access to all IAM content